{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T21:41:27Z","timestamp":1764020487116,"version":"build-2065373602"},"reference-count":153,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>To date, the only treatment for celiac disease (CD) consists of a strict lifelong gluten-free diet (GFD), which has numerous limitations in patients with CD. For this reason, dietary transgressions are frequent, implying intestinal damage and possible long-term complications. There is an unquestionable need for non-dietary alternatives to avoid damage by involuntary contamination or voluntary dietary transgressions. In recent years, different therapies and treatments for CD have been developed and studied based on the degradation of gluten in the intestinal lumen, regulation of the immune response, modulation of intestinal permeability, and induction of immunological tolerance. In this review, therapeutic lines for CD are evaluated with special emphasis on phase III and II clinical trials, some of which have promising results.<\/jats:p>","DOI":"10.3390\/nu13072146","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T03:22:00Z","timestamp":1624418520000},"page":"2146","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["New Insights into Non-Dietary Treatment in Celiac Disease: Emerging Therapeutic Options"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9600-8979","authenticated-orcid":false,"given":"Ver\u00f3nica","family":"Segura","sequence":"first","affiliation":[{"name":"Departamento de Microbiolog\u00eda y Parasitolog\u00eda, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7100-846X","authenticated-orcid":false,"given":"\u00c1ngela","family":"Ruiz-Carnicer","sequence":"additional","affiliation":[{"name":"Departamento de Microbiolog\u00eda y Parasitolog\u00eda, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Sousa","sequence":"additional","affiliation":[{"name":"Departamento de Microbiolog\u00eda y Parasitolog\u00eda, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7490-2037","authenticated-orcid":false,"given":"Mar\u00eda de Lourdes","family":"Moreno","sequence":"additional","affiliation":[{"name":"Departamento de Microbiolog\u00eda y Parasitolog\u00eda, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"j1892","DOI":"10.1136\/bmj.j1892","article-title":"Long-term gluten consumption in adults without celiac disease and risk of coronary heart disease: Prospective cohort study","volume":"357","author":"Lebwohl","year":"2017","journal-title":"BMJ"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/2050640619844125","article-title":"European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders","volume":"7","author":"Volta","year":"2019","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(17)31796-8","article-title":"Coeliac disease","volume":"391","author":"Lebwohl","year":"2018","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gtc.2018.09.004","article-title":"Epidemiology of celiac disease","volume":"48","author":"Ludvigsson","year":"2019","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","article-title":"Global prevalence of celiac disease: Systematic review and meta-analysis","volume":"16","author":"Singh","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/20469047.2018.1504431","article-title":"Coeliac disease","volume":"39","author":"Glissen","year":"2019","journal-title":"Paediatr. Int. Child. Health."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1007\/s10620-014-3514-7","article-title":"Racial differences in the prevalence of celiac disease in the US population: National Health and Nutrition Examination Survey (NHANES) 2009\u20132012","volume":"60","author":"Mardini","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","article-title":"European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease","volume":"54","author":"Husby","year":"2012","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ajg.2013.79","article-title":"American College of Gastroenterology. ACG clinical guidelines: Diagnosis and management of celiac disease","volume":"108","author":"Hill","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/gutjnl-2013-306578","article-title":"Diagnosis and management of adult coeliac disease: Guidelines from the British Society of Gastroenterology","volume":"63","author":"Ludvigsson","year":"2014","journal-title":"Gut"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1053\/j.gastro.2014.12.049","article-title":"Nonceliac gluten sensitivity","volume":"148","author":"Fasano","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Arranz, E., and Fern\u00e1ndez-Ba\u00f1ares, F. (2015). Analytical tools for gluten detection. Policies and regulation. Advances in the Understanding of Gluten Related Pathology and the Evolution of Gluten-Free Foods, OmniaScience.","DOI":"10.3926\/oms.274"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Caio, G., Volta, U., Sapone, A., Leffler, D.A., De Giorgio, R., Catassi, C., and Fasano, A. (2019). Celiac disease: A comprehensive current review. BMC Med., 17.","DOI":"10.1186\/s12916-019-1380-z"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fnut.2020.00006","article-title":"Pathogenesis of celiac disease and other gluten related disorders in wheat and strategies for mitigating them","volume":"7","author":"Sharma","year":"2020","journal-title":"Front. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-018-0054-z","article-title":"Coeliac disease","volume":"5","author":"Lindfors","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/gast.2000.18149","article-title":"Interleukin 15 mediates epithelialmchanges in celiac disease","volume":"119","author":"Maiuri","year":"2000","journal-title":"Gastroenterology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0140-6736(03)13803-2","article-title":"Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease","volume":"362","author":"Maiuri","year":"2003","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.4049\/jimmunol.173.3.1757","article-title":"Antigen presentation to celiac lesion-derived t cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion","volume":"173","author":"Qiao","year":"2004","journal-title":"J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/j.gastro.2006.06.002","article-title":"A Unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells","volume":"131","author":"Tollefsen","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1172\/JCI27620","article-title":"HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease","volume":"116","author":"Tollefsen","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3389\/fpls.2019.00721","article-title":"Plant Proteases: From key enzymes in germination to allies for fighting human gluten-related disorders","volume":"10","author":"Martinez","year":"2019","journal-title":"Front. Plant Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.molmet.2017.05.008","article-title":"The human digestive tract has proteases capable of gluten hydrolysis","volume":"6","author":"Ferrero","year":"2017","journal-title":"Mol. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/apt.13725","article-title":"Symptomatic suspected gluten exposure is common among patients with coeliac disease on a gluten-free diet","volume":"44","author":"Silvester","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.cgh.2020.03.038","article-title":"Real-world gluten exposure in patients with celiac disease on gluten-free diets, determined from gliadin immunogenic peptides in urine and fecal samples","volume":"19","author":"Stefanolo","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1007\/s10620-018-4936-4","article-title":"Hypervigilance to a gluten-free diet and decreased quality of life in teenagers and adults with celiac disease","volume":"63","author":"Wolf","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Khoury, D.E., Balfour-Ducharme, S., and Joye, I.J. (2018). A review on the gluten-free diet: Technological and nutritional challenges. Nutrients, 10.","DOI":"10.3390\/nu10101410"},{"key":"ref_27","unstructured":"(2021, January 07). Codex Standard 118-1979. Available online: http:\/\/www.fao.org\/fao-who-codexalimentarius\/sh-proxy\/en\/?lnk=1&url=https%253A%252F%252Fworkspace.fao.org%252Fsites%252Fcodex%252FStandards%252FCXS%2B118-1979%252FCXS_118e_2015.pdf."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e0007","DOI":"10.5041\/RMMJ.10360","article-title":"Gluten in celiac disease-more or less?","volume":"10","author":"Cohen","year":"2019","journal-title":"Rambam Maimonides Med. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/MPG.0000000000002676","article-title":"Adherence to gluten-free diet in a celiac pediatric population referred to the general pediatrician after remission","volume":"71","author":"Sbravati","year":"2020","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Tovoli, F., Negrini, G., Sansone, V., Faggiano, C., Catenaro, T., Bolondi, L., and Granito, A. (2018). Celiac disease diagnosed through screening programs in at-risk adults is not associated with worse adherence to the gluten-free diet and might protect from osteopenia\/osteoporosis. Nutrients, 10.","DOI":"10.3390\/nu10121940"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.clinre.2019.12.014","article-title":"Factors associated with non adherence to a gluten free diet in adult with celiac disease: A survey assessed by BIAGI score","volume":"44","author":"Dana","year":"2020","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/gutjnl-2015-310148","article-title":"Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing","volume":"66","author":"Moreno","year":"2017","journal-title":"Gut"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/apt.12893","article-title":"Histological recovery and gluten-free diet adherence: A prospective 1-year follow-up study of adult patients with coeliac disease","volume":"40","author":"Galli","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/ajcn\/nqaa188","article-title":"Negative predictive value of the repeated absence of gluten immunogenic peptides in the urine of treated celiac patients in predicting mucosal healing: New proposals for follow-up in celiac disease","volume":"112","author":"Fombuena","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.14309\/ajg.0000000000001139","article-title":"Persistent villous atrophy in de novo adult patients with celiac disease and strict control of gluten-free diet adherence: A multicenter prospective study (CADER Study)","volume":"116","author":"Salas","year":"2021","journal-title":"Am. J. Gastoenterol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/jhn.12754","article-title":"Facilitators and barriers to adherence to gluten-free diet among adults with celiac disease: A systematic review","volume":"33","author":"Jaana","year":"2020","journal-title":"J. Hum. Nutr. Diet"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.dld.2019.11.010","article-title":"Therapeutic options for coeliac disease: What else beyond gluten-free diet?","volume":"52","author":"Caio","year":"2020","journal-title":"Digest. Liver Dis."},{"key":"ref_38","first-page":"248402","article-title":"Predictors of compliance to gluten-free diet in children with celiac disease","volume":"2014","author":"Garg","year":"2014","journal-title":"Int. Sch. Res. Not."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/ajg.2016.439","article-title":"Fecal gluten peptides reveal limitations of serological tests and food questionnaires for monitoring gluten-free diet in celiac disease patients","volume":"111","author":"Comino","year":"2016","journal-title":"Am. J. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Czaja-Bulsa, G., and Bulsa, M. (2018). Adherence to gluten-free diet in children with celiac disease. Nutrients, 10.","DOI":"10.3390\/nu10101424"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/MPG.0000000000002062","article-title":"Comparison of clinical methods with the faecal gluten immunogenic peptide to assess gluten intake in coeliac disease","volume":"67","author":"Gerasimidis","year":"2018","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.21101\/cejph.a5369","article-title":"Compliance with gluten-free diet in a selected group of celiac children in the Slovak Republic","volume":"26","author":"Dorko","year":"2018","journal-title":"Cent. Eur. J. Public Health"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/apt.15277","article-title":"Prospective longitudinal study: Use of faecal gluten immunogenic peptides to monitor children diagnosed with coeliac disease during transition to a gluten-free diet","volume":"49","author":"Comino","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_44","first-page":"377","article-title":"Estudio de la adherencia a la dieta sin gluten en pacientes celiacos [Study of adherence to the gluten-free diet in coeliac patients]","volume":"94","year":"2020","journal-title":"An. Pediatr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s00394-020-02404-z","article-title":"Analysis of gluten immunogenic peptides in feces to assess adherence to the gluten-free diet in pediatric celiac patients","volume":"60","author":"Roca","year":"2020","journal-title":"Eur. J. Nutr."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Rodrigues, M., Yonamine, G.H., and Fernandes-Satiro, C.A. (2018). Rate and determinants of nonadherence to a gluten-free diet and nutritional status assessment in children and adolescents with celiac disease in a tertiary Brazilian referral center: A cross-sectional and retrospective study. BMC Gastroenterol., 18.","DOI":"10.1186\/s12876-018-0740-z"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1177\/2050640618787651","article-title":"Coeliac disease: Factors affecting the transition and a practical tool for the transition to adult healthcare","volume":"6","author":"Zingone","year":"2018","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/MPG.0000000000002451","article-title":"Celiac dietary adherence test simplifies determining adherence to a gluten-free diet in swedish adolescents","volume":"69","author":"Johansson","year":"2019","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/apt.13319","article-title":"Factors governing long-term adherence to a gluten-free diet in adult patients with coeliac disease","volume":"42","author":"Vanga","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_50","first-page":"229","article-title":"Adherence to a gluten-free diet in mexican subjects with gluten-related \u00a1disorders: A high prevalence of inadvertent gluten intake","volume":"68","year":"2016","journal-title":"Rev. Investig. Clin."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.nut.2016.01.021","article-title":"Is it gluten-free? Relationship between self-reported gluten-free diet adherence and knowledge of gluten content of foods","volume":"32","author":"Silvester","year":"2016","journal-title":"Nutrition"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Muhammad, H., Reeves, S., Ishaq, S., Mayberry, J., and Jeanes, Y.M. (2017). Adherence to a gluten free diet is associated with receiving gluten free foods on prescription and understanding food labelling. Nutrients, 9.","DOI":"10.3390\/nu9070705"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/apt.14791","article-title":"Food knowledge and psychological state predict adherence to a gluten-free diet in a survey of 5310 Australians and New Zealanders with coeliac disease","volume":"48","author":"Halmos","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3748\/wjg.v25.i11.1409","article-title":"Gluten immunogenic peptide excretion detects dietary transgressions in treated celiac disease patients","volume":"25","author":"Costa","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/SGA.0000000000000368","article-title":"Is adherence to a gluten-free diet by adult patients with celiac disease influenced by their knowledge of the gluten content of foods?","volume":"42","author":"Paganizza","year":"2019","journal-title":"Gastroenterol. Nurs."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1080\/08870446.2019.1675658","article-title":"The effect of self-efficacy expectations in the adherence to a gluten free diet in celiac disease","volume":"35","author":"Navarro","year":"2020","journal-title":"Psychol. Health"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1053\/j.gastro.2019.12.016","article-title":"The DOGGIE BAG study group. Most patients with celiac disease on gluten-free diets consume measurable amounts of gluten","volume":"158","author":"Silvester","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/apt.16075","article-title":"Exposure sources, amounts and time course of gluten ingestion and excretion in patients with coeliac disease on a gluten-free diet","volume":"52","author":"Silvester","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/pbi.12482","article-title":"Creation of the first ultra-low gluten barley (Hordeum vulgare L.) for coeliac and gluten-intolerant populations","volume":"14","author":"Tanner","year":"2016","journal-title":"Plant Biotechnol. J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/pbi.12837","article-title":"Low-gluten, nontransgenic wheat engineered with CRISPR\/Cas9","volume":"16","author":"Ozuna","year":"2018","journal-title":"Plant Biotechnol. J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ygh2.371","article-title":"Latiglutenase treatment for celiac disease: Symptom and quality of life improvement for seropositive patients on a gluten-free diet","volume":"1","author":"Syage","year":"2019","journal-title":"GastroHep"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"H\u00e5kansson, \u00c5., Andr\u00e9n-Aronsson, C., Brundin, C., Oscarsson, E., Molin, G., and Agardh, D. (2019). Effects of Lactobacillus plantarum and Lactobacillus paracasei on the peripheral immune response in children with celiac disease autoimmunity: A randomized, double-blind, placebo-controlled clinical trial. Nutrients, 11.","DOI":"10.3390\/nu11081925"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1021\/jf501275c","article-title":"Microbial transglutaminase treatment in pasta-production does not affect the immunoreactivity of gliadin with celiac disease patients\u2019 sera","volume":"62","author":"Ruh","year":"2014","journal-title":"J. Agric. Food Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/bip.21109","article-title":"Interaction of alpha-gliadin with poly (HEMA-co-SS): Structural characterization and biological implication","volume":"91","author":"Liang","year":"2009","journal-title":"Biopolymers"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/j.gastro.2011.10.038","article-title":"The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues","volume":"142","author":"Pinier","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_66","unstructured":"Allu\u00e9, P. (2013). Nuevas estrategias terap\u00e9uticas en la enfermedad cel\u00edaca. Enfermedad Cel\u00edaca: Presente y Future, Ergon."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"8192","DOI":"10.1016\/S0021-9258(18)42426-X","article-title":"Characterization of a prolyl endopeptidase from flavobacterium meningosepticum. complete sequence and localization of the active-site serine","volume":"267","author":"Chevallier","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/BF00170434","article-title":"Cloning of proline-specific endopeptidase gene from Flavobacterium meningosepticum: Expression in Escherichia coli and purification of the heterologous protein","volume":"40","author":"Diefenthal","year":"1993","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1042\/BJ20040907","article-title":"Comparative biochemical analysis of three bacterial prolyl endopeptidases: Implications for coeliac sprue","volume":"383 Pt 2","author":"Shan","year":"2004","journal-title":"Biochem. J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/abbi.1998.0836","article-title":"Prolyl endopeptidase from Sphingomonas capsulata: Isolation and characterization of the enzyme and nucleotide sequence of the gene","volume":"358","author":"Kabashima","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"112499","DOI":"10.1016\/j.ejmech.2020.112499","article-title":"Rationally engineered prolyl endopeptidases from Sphingomonas capsulata with improved hydrolytic activity towards pathogenic peptides of celiac diseases","volume":"15","author":"Xiao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00217-015-2617-5","article-title":"Production of gluten-free beer by peptidase treatment","volume":"242","author":"Knorr","year":"2016","journal-title":"Eur. Food Res. Technol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/j.gastro.2014.02.031","article-title":"Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease","volume":"146","author":"Kaukinen","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fnut.2020.00011","article-title":"Directed-Mutagenesis of Flavobacterium meningosepticum prolyl-oligopeptidase and a glutamine-specific endopeptidase from barley","volume":"7","author":"Osorio","year":"2020","journal-title":"Front. Nutr."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1038\/s41598-019-43837-9","article-title":"Pharmaceutically modified subtilisins withstand acidic conditions and effectively degrade gluten in vivo","volume":"9","author":"Darwish","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2468-1253(19)30264-X","article-title":"Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: A phase 2a, randomised, double-blind, placebo-controlled study","volume":"4","author":"Scheinin","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.molimm.2009.10.036","article-title":"Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule","volume":"47","author":"Kapoerchan","year":"2010","journal-title":"Mol. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1084\/jem.20150303","article-title":"Cysteinyl leukotrienes mediate lymphokine killer activity induced by NKG2D and IL-15 in cytotoxic T cells during celiac disease","volume":"212","author":"Tang","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e15949","DOI":"10.1097\/MD.0000000000015949","article-title":"The role of CXCR3 and its ligands CXCL10 and CXCL11 in the pathogenesis of celiac disease","volume":"98","author":"Haghbin","year":"2019","journal-title":"Medicine"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S2468-1253(19)30265-1","article-title":"Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: A phase 2a, randomised, double-blind, placebo-controlled, parallel-group study","volume":"4","author":"Cellier","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1002\/jcp.26217","article-title":"Mesalazine treatment in organotypic culture of celiac patients: Comparative study with gluten free diet","volume":"233","author":"Benedetti","year":"2018","journal-title":"J. Cell Physiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1053\/j.gastro.2015.02.008","article-title":"Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: A randomized controlled trial","volume":"148","author":"Leffler","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1756283X15616576","article-title":"The potential utility of tight junction regulation in celiac disease: Focus on larazotide acetate","volume":"9","author":"Khaleghi","year":"2016","journal-title":"Therap. Adv. Gastroenterol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ebiom.2017.11.018","article-title":"Epitope-specific immunotherapy targeting CD4-positive T cells in celiac disease: Safety, pharmacokinetics, and effects on intestinal histology and plasma cytokines with escalating dose regimens of NEXVAX2 in a randomized, double-blind, placebo-controlled phase 1 study","volume":"26","author":"Daveson","year":"2017","journal-title":"EBioMedicine"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S2468-1253(17)30110-3","article-title":"Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: Two randomised, double-blind, placebo-controlled phase 1 studies","volume":"2","author":"Goel","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_86","unstructured":"(2021, January 05). Database ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04530123."},{"key":"ref_87","unstructured":"(2021, January 06). Database ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04248855."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jaci.2014.07.022","article-title":"Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease","volume":"135","author":"Croese","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1038\/s41598-019-43426-w","article-title":"Human gut derived-organoids provide model to study gluten response and effects of microbiota-derived molecules in celiac disease","volume":"9","author":"Freire","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Cristofori, F., Indrio, F., Miniello, V.L., De Angelis, M., and Francavilla, R. (2018). Probiotics in celiac disease. Nutrients, 10.","DOI":"10.3390\/nu10121824"},{"key":"ref_91","first-page":"S1","article-title":"The potentials of probiotics on gluten hydrolysis; a review study","volume":"13","author":"Ramedani","year":"2020","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Zanini, B., Petroboni, B., Not, T., di Toro, N., Villanacci, V., Lanzarotto, F., Pogna, N., Ricci, C., and Lanzini, A. (2013). Search for atoxic cereals: A single blind, cross-over study on the safety of a single dose of Triticum monococcum, in patients with celiac disease. BMC Gastroenterol., 13.","DOI":"10.1186\/1471-230X-13-92"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/jsfa.8705","article-title":"Tritordeum: A novel cereal for food processing with good acceptability and significant reduction in gluten immunogenic peptides in comparison with wheat","volume":"98","author":"Vaquero","year":"2018","journal-title":"J. Sci. Food Agric."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnut.2020.00051","article-title":"CRISPR\/Cas9 gene editing of gluten in wheat to reduce gluten content and exposure-reviewing methods to screen for coeliac safety","volume":"7","author":"Jouanin","year":"2020","journal-title":"Front. Nutr."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MCO.0b013e3282f795f8","article-title":"Issues related to gluten-free diet in coeliac disease","volume":"11","author":"Troncone","year":"2008","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/pbi.12455","article-title":"Targeting of prolamins by RNAi in bread wheat: Effectiveness of seven silencing-fragment combinations for obtaining lines devoid of coeliac disease epitopes from highly immunogenic gliadins","volume":"14","author":"Barro","year":"2016","journal-title":"Plant Biotechnol. J."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Haro, C., Villatoro, M., Vaquero, L., Pastor, J., Gim\u00e9nez, M.J., Ozuna, C.V., S\u00e1nchez-Le\u00f3n, S., Garc\u00eda-Molina, M.D., Segura, V., and Comino, I. (2018). The dietary intervention of transgenic low-gliadin wheat bread in patients with non-celiac gluten sensitivity (NCGS) showed no differences with gluten free diet (GFD) but provides better gut microbiota profile. Nutrients, 10.","DOI":"10.3390\/nu10121964"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/lam.12525","article-title":"Development of a Type I gluten-free sourdough","volume":"62","author":"Picozzi","year":"2016","journal-title":"Lett. Appl. Microbiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s00253-021-11263-5","article-title":"Gluten-degrading bacteria: Availability and applications","volume":"105","author":"Tenson","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1097\/MCG.0000000000001023","article-title":"Clinical and microbiological effect of a multispecies probiotic supplementation in celiac patients with persistent ibs-type symptoms: A randomized, double-blind, placebo-controlled, multicenter trial","volume":"53","author":"Francavilla","year":"2019","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbadis.2005.09.008","article-title":"VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for Celiac Sprue","volume":"1762","author":"Rizzello","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"9048574","DOI":"10.1155\/2016\/9048574","article-title":"Probiotics and the microbiome in celiac disease: A Randomised Controlled Trial","volume":"2016","author":"Harnett","year":"2016","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.gastrohep.2017.12.002","article-title":"Nuevas terapias en la enfermedad celiaca y sus complicaciones","volume":"41","author":"Vaquero","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clim.2018.12.008","article-title":"Microbial transglutaminase: A new potential player in celiac disease","volume":"199","author":"Aaron","year":"2019","journal-title":"Clin. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1053\/j.gastro.2017.06.017","article-title":"Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas","volume":"153","author":"Zhou","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"McCarville, J.L., Nisemblat, Y., Galipeau, H.J., Jury, J., Tabakman, R., Cohen, A., Naftali, E., Neiman, B., Halbfinger, E., and Murray, J.A. (2014). BL-7010 demonstrates specific binding to gliadin and reduces gluten-associated pathology in a chronic mouse model of gliadin sensitivity. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0109972"},{"key":"ref_107","unstructured":"(2021, March 10). Database ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03707730."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Stadlmann, V., Harant, H., Korschineck, I., Hermann, M., Forster, F., and Missbichler, A. (2015). Novel avian single-chain fragment variable (scFv) targets dietary gluten and related natural grain prolamins, toxic entities of celiac disease. BMC Biotechnol., 15.","DOI":"10.1186\/s12896-015-0223-z"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Moreno, M.L., Ar\u00e9valo-Rodr\u00edguez, M., Mellado, E., Mart\u00ednez-Reyes, J.C., and Sousa, C. (2019). A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0218346"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/1756283X17690991","article-title":"Commercially available glutenases: A potential hazard in coeliac disease","volume":"10","author":"Krishnareddy","year":"2017","journal-title":"Therap. Adv. Gastroenterol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"601854","DOI":"10.3389\/fmed.2020.601854","article-title":"Verifying diagnosis of refractory celiac disease with urine gluten immunogenic peptides as biomarker","volume":"7","author":"Moreno","year":"2021","journal-title":"Front. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"G769","DOI":"10.1152\/ajpgi.00144.2014","article-title":"Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease","volume":"307","author":"Tian","year":"2014","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"101","DOI":"10.15414\/jmbfs.2015.4.special2.101-104","article-title":"The use of different proteases to hydrolyze gliadins","volume":"4","author":"Socha","year":"2015","journal-title":"J. Microbiol. Biotechnol. Food Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/ajg.2015.97","article-title":"Identification of pseudolysin (lasB) as an aciduric gluten-degrading enzymewith high therapeutic potential for celiac disease","volume":"110","author":"Wei","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s12602-017-9331-5","article-title":"Significant hydrolysis of wheat gliadin by bacillus tequilensis (10bT\/HQ223107): A Pilot Study","volume":"10","author":"Wagh","year":"2018","journal-title":"Probiotics Antimicrob. Proteins."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12934-020-01388-z","article-title":"Gluten hydrolyzing activity of Bacillus spp isolated from sourdough","volume":"19","author":"Rashmi","year":"2020","journal-title":"Microb. Cell Factories"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"13147","DOI":"10.1038\/s41598-019-48299-7","article-title":"E40, a novel microbial protease efficiently detoxifying gluten proteins, for the dietary management of gluten intolerance","volume":"9","author":"Cavaletti","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Ehren, J., Mor\u00f3n, B., Martin, E., Bethune, M.T., Gray, G.M., and Khosla, C. (2009). A foodgrade enzyme preparation with modest gluten detoxification properties. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006313"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Janssen, G., Christis, C., Kooy-Winkelaar, Y., Edens, L., Smith, D., van Veelen, P., and Koning, F. (2015). Ineffective degradation of immunogenic gluten epitopes by currently available enzyme supplements. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0128065"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Bethune, M.T., Ribka, E., Khosla, C., and Sestak, K. (2008). Transepithelial transport and enzymatic detoxification of gluten in gluten-sensitive rhesus macaques. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0001857"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00726-008-0223-6","article-title":"Papaya latex enzymes capable of detoxification of gliadin","volume":"38","author":"Cornell","year":"2009","journal-title":"Amino Acids"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biocel.2015.03.001","article-title":"Glutenase and collagenase activities of wheat cysteine protease Triticain-\u03b1: Feasibility for enzymatic therapy assays","volume":"62","author":"Savvateeva","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.1007\/s00253-015-6838-0","article-title":"Prolyl-specific peptidases for applications in food protein hydrolysis","volume":"99","author":"Mika","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"e21395","DOI":"10.1002\/arch.21395","article-title":"Prolidase is a critical enzyme for complete gliadin digestion in Tenebrio molitor larvae","volume":"95","author":"Tereshchenkova","year":"2017","journal-title":"Arch. Insect Biochem. Physiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1053\/j.gastro.2016.11.004","article-title":"No difference between latiglutenase and placebo in reducing villous atrophy or improving symptoms in patients with symptomatic celiac disease","volume":"152","author":"Murray","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1007\/s10620-017-4687-7","article-title":"Latiglutenase improves symptoms in seropositive celiac disease patients while on a gluten-free diet","volume":"62","author":"Syage","year":"2017","journal-title":"Dig. Dis. Sci."},{"key":"ref_127","unstructured":"(2021, March 13). Database ClinicalTrials.gov. Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03585478."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/gut.2006.111609","article-title":"Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: Implications for coeliac disease","volume":"57","author":"Mitea","year":"2008","journal-title":"Gut"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1016\/j.bmc.2007.07.001","article-title":"Cyclic and dimeric gluten peptide analogues inhibiting DQ2-mediated antigen presentation in celiac disease","volume":"15","author":"Xia","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.2174\/092986707782023343","article-title":"New therapeutic strategies for coeliac disease: Tissue transglutaminase as a target","volume":"14","author":"Esposito","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jcmgh.2019.04.017","article-title":"Novel nondietary therapies for celiac disease","volume":"8","author":"Alhassan","year":"2019","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1021\/acs.biochem.8b00204","article-title":"Cystamine and disulfiram inhibit human transglutaminase 2 via an oxidative mechanism","volume":"57","author":"Palanski","year":"2018","journal-title":"Biochemistry"},{"key":"ref_133","unstructured":"(2021, April 01). Database ClinicalTrials.gov. Available online: https:\/\/grantome.com\/grant\/NIH\/R01-DK100619-01A1."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1365-2796.2011.02376.x","article-title":"Novel therapies for coeliac disease","volume":"269","author":"Sollid","year":"2011","journal-title":"J. Intern. Med."},{"key":"ref_135","unstructured":"(2021, April 01). Database ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04593251."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2174\/138945010790309894","article-title":"How to manage loss of response to anti-TNF in Crohn\u2019s disease?","volume":"11","author":"Reinisch","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1002\/ibd.21716","article-title":"Natalizumab to kill two birds with one stone: A case of celiac disease and multiple sclerosis","volume":"17","author":"Lambinet","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.3389\/fimmu.2018.01700","article-title":"Effects of anti-integrin treatment with vedolizumab on immune pathways and cytokines in inflammatory bowel diseases","volume":"9","author":"Rath","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.4049\/jimmunol.178.5.3293","article-title":"Phenotype and effector function of CC chemokine receptor 9-expressing lymphocytes in small intestinal Crohn\u2019s disease","volume":"178","author":"Saruta","year":"2007","journal-title":"J. Immunol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1124\/jpet.110.169714","article-title":"Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease","volume":"335","author":"Walters","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41575-020-00378-1","article-title":"Current and emerging therapies for coeliac disease","volume":"18","author":"Caminero","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.peptides.2012.02.016","article-title":"Larazotide acetate promotes tight junction assembly in epithelial cells","volume":"35","author":"Gopalakrishnan","year":"2012","journal-title":"Peptides"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.peptides.2012.02.015","article-title":"Larazotide acetate regulates epithelial tight junctions in vitro and in vivo","volume":"35","author":"Gopalakrishnan","year":"2012","journal-title":"Peptides"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.gtc.2018.09.011","article-title":"Nondietary therapies for celiac disease","volume":"48","author":"Serena","year":"2019","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_145","first-page":"41ra51","article-title":"Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease","volume":"2","author":"Stewart","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref_146","unstructured":"(2021, April 10). Database ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03738475."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Daveson, A.J., Jones, D.M., Gaze, S., McSorley, H., Clouston, A., Pascoe, A., Cooke, S., Speare, R., Macdonald, G.A., and Anderson, R. (2011). Effect of hookworm infection on wheat challenge in celiac disease-a randomised double-blinded placebo-controlled trial. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0017366"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Chibbar, R., and Dieleman, L.A. (2019). The gut microbiota in celiac disease and probiotics. Nutrients, 11.","DOI":"10.3390\/nu11102375"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.gastrohep.2019.04.001","article-title":"Metabolism of wheat proteins by intestinal microbes: Implications for wheat related disorders","volume":"42","author":"Caminero","year":"2019","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1007\/s00253-019-09842-8","article-title":"Genetically engineered probiotic Saccharomyces cerevisiae strains mature human dendritic cells and stimulate Gag-specific memory CD8+ T cells ex vivo","volume":"103","author":"Palma","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/17474124.2020.1745630","article-title":"Advances in understanding the potential therapeutic applications of gut microbiota and probiotic mediated therapies in celiac disease","volume":"14","author":"Francavilla","year":"2020","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","article-title":"What are biomarkers?","volume":"5","author":"Strimbu","year":"2010","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/gastro\/gov006","article-title":"Development of drugs for celiac disease: Review of endpoints for Phase 2 and 3 trials","volume":"3","author":"Gottlieb","year":"2015","journal-title":"Gastroenterol. Rep."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/7\/2146\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:21:34Z","timestamp":1760163694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/7\/2146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,23]]},"references-count":153,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["nu13072146"],"URL":"https:\/\/doi.org\/10.3390\/nu13072146","relation":{},"ISSN":["2072-6643"],"issn-type":[{"type":"electronic","value":"2072-6643"}],"subject":[],"published":{"date-parts":[[2021,6,23]]}}}